NCRI 2019 | Aberrrant transcriptional programming in AML

Constanze Bonifer

Constanze Bonifer, PhD, University of Birmingham, Birmingham, UK, talks about sub-type specific aberrant transcriptional programming in acute myeloid leukemia (AML). Recorded at the 2019 National Cancer Research Institute (NCRI) Annual Cancer Conference, in Glasgow, UK.
For more information about the NCRI Cancer Conference, visit https://conference.ncri.org.uk.

Share this video